{"url":"https://whatshealthyandwhy.com/vertigo/natural-management","path":"/vertigo/natural-management","alternates":{"json":"https://whatshealthyandwhy.com/api/articles/vertigo/natural-management.json","markdown":"https://whatshealthyandwhy.com/vertigo/natural-management.md"},"topic":{"slug":"vertigo","name":"Vertigo","url":"https://whatshealthyandwhy.com/vertigo"},"slug":"natural-management","order":1,"title":"Natural Management of Vertigo","question":"Does the Epley maneuver cure vertigo, and can vitamin D stop it returning?","answer":"The Epley maneuver probably clears BPPV, the commonest vertigo, in a few sessions; vitamin D with calcium lowered recurrence in a 1,050-person trial.","description":"Evidence-based approaches to BPPV and vestibular vertigo — Epley maneuver, vitamin D supplementation, vestibular rehabilitation exercises, and Ginkgo biloba — supported by Cochrane reviews and randomized trials","confidence":4,"confidenceNote":"Cochrane (11 RCTs, 745 people) favors Epley about 8 to 1 over sham; vitamin D rests on one 1,050-person trial plus mostly non-randomized studies.","evidenceSummary":{"rctCount":2,"observationalCount":0,"metaAnalysisCount":3,"totalParticipants":"2,600+","replicated":true,"newestStudyYear":2022},"category":{"categoryTitle":"Your Body","categorySlug":"your-body","subcategoryName":"Body Systems","subcategorySlug":"systems","url":"https://whatshealthyandwhy.com/explore/your-body/systems"},"actions":["Ask a clinician to confirm BPPV and perform the Epley maneuver; it takes under five minutes and often works within three sessions [1].","If BPPV recurs, check vitamin D; the trial gave low-level patients (<20 ng/mL) 400 IU plus 500 mg calcium twice daily [2].","For lingering dizziness, try vestibular rehabilitation exercises (gaze, balance and habituation), 10–20 minutes twice daily for 6–8 weeks [4]."],"cautions":["Vertigo is a symptom; get the cause checked, since Meniere's disease, vestibular neuritis and neck-related dizziness need different care.","The vitamin D trial also gave calcium, so vitamin D's own effect is unclear; benefit was larger with confirmed deficiency [2].","Ginkgo (EGb 761) matched betahistine in a 160-person trial with no placebo group, so its absolute benefit is unproven [5]."],"simpleText":"Vertigo — the unsettling false sensation that you or the room is spinning — affects roughly one in five people at some point in their lives, with the most common cause being benign paroxysmal positional vertigo (BPPV), a condition in which tiny calcium carbonate crystals in the inner ear become dislodged and float into the fluid-filled canals that sense rotation. The most powerful intervention is not a medication but a precisely timed sequence of head movements called the Epley maneuver, which guides those displaced crystals back where they belong: a Cochrane review of 11 trials found it resolves BPPV in most patients within one or two office sessions [1]. For people prone to recurring episodes, correcting vitamin D deficiency dramatically reduces the chance of another attack — a large multicenter trial and subsequent meta-analysis both confirm significant recurrence prevention when vitamin D is brought to normal levels [2][3].","mediumText":"Understanding the Types of Vertigo\n\nVertigo is a symptom rather than a diagnosis, so the most important first step is identifying its cause.\n\nBenign paroxysmal positional vertigo (BPPV) is by far the most common cause, accounting for roughly half of all vertigo cases. It produces brief, intense spinning episodes — typically lasting under a minute — triggered by specific head movements such as rolling over in bed, looking up, or tipping the head forward. BPPV occurs when otoconia (small calcium crystite crystals that normally sit in the utricle, one of the inner ear's gravity-sensing organs) break loose and migrate into one of the three semicircular canals. The crystals generate inappropriate motion signals when the head moves, producing the characteristic spinning sensation.\n\nVestibular neuritis and labyrinthitis follow a viral infection and typically cause a single prolonged episode of severe vertigo lasting hours to days, often with nausea and imbalance. These conditions resolve as the brain adapts (vestibular compensation), but targeted exercises can accelerate recovery considerably.\n\nMeniere's disease involves fluid imbalance in the inner ear and produces episodic vertigo lasting 20 minutes to several hours, accompanied by fluctuating hearing loss, ear fullness, and tinnitus. Management is more complex and typically requires specialist involvement.\n\nCervicogenic dizziness originates in the neck and upper spine — proprioceptive dysfunction from cervical joint problems or muscle tension — and is best addressed through manual therapy and targeted neck exercises.\n\nThe Epley Maneuver: The Primary Treatment for BPPV\n\nThe Epley maneuver — a sequence of four head and body positions each held for about 30 seconds — is the standard first-line treatment for posterior canal BPPV, which is the most common variant. The maneuver uses gravity to guide displaced otoconia out of the semicircular canal and back into the utricle, where they dissolve or cause no symptoms.\n\nThe basic sequence for right-ear posterior canal BPPV:\n1. Sit upright on a bed with your head turned 45 degrees to the right\n2. Quickly lie back with your head hanging slightly off the edge, still turned right — hold until the dizziness stops, plus 30 seconds\n3. Turn your head 90 degrees to the left (now facing left 45 degrees) — hold 30 seconds\n4. Roll your body and head together to face fully left with your nose pointing downward — hold 30 seconds\n5. Sit up slowly on the left side of the bed\n\nFor left-ear BPPV, the sequence mirrors in the opposite direction. A clinician can help determine which ear is affected using the Dix-Hallpike test before performing the maneuver. Most patients experience complete resolution within one to three sessions. A physiotherapist, ENT specialist, or well-trained vestibular physiotherapist can perform this in under five minutes.\n\nThe Cochrane review found that a single Epley maneuver makes patients eight times more likely to resolve their vertigo than sham treatment, with a conversion to negative Dix-Hallpike test in about 80% of cases in the short term [1].\n\nBrandt-Daroff Exercises: Home Habituation\n\nBrandt-Daroff exercises are a home-based series of rapid lateral tilts designed to habituate the vestibular system to the abnormal signals generated by displaced crystals. While less effective than the Epley maneuver at immediately clearing BPPV, they help accelerate vestibular compensation and are useful when the Epley maneuver is not accessible or has not fully resolved symptoms.\n\nBasic technique:\n1. Sit upright on the edge of a bed\n2. Quickly lie down on your right side with your head tilted 45 degrees upward — hold 30 seconds or until dizziness resolves\n3. Return to sitting, hold 30 seconds\n4. Quickly lie down on your left side with your head still tilted upward — hold 30 seconds\n5. Return to sitting — this is one cycle\n\nRepeat 5 cycles twice daily. Most people see significant relief within two to four weeks. The exercises feel uncomfortable at first because they deliberately trigger the dizziness, but repeated exposure prompts the brain to learn that the signals are benign and gradually suppress them.\n\nVestibular Rehabilitation Therapy\n\nFor people with chronic vestibular disorders — persistent dizziness after vestibular neuritis, incomplete recovery from BPPV, or dizziness from bilateral vestibular loss — formal vestibular rehabilitation therapy (VRT) offers the most evidence-based structured approach. VRT is an exercise-based treatment performed by trained physiotherapists. It includes three categories of exercises:\n\n- Gaze stabilization exercises (moving the head while tracking a fixed target) to improve visual-vestibular coordination\n- Balance and postural exercises to reduce fall risk and improve stability on uneven ground\n- Habituation exercises to reduce sensitivity to head movements that provoke dizziness\n\nA systematic review found that vestibular rehabilitation significantly improved vertigo symptom scores, balance, fall risk, and emotional wellbeing compared to no treatment or routine medical care, with benefits across multiple vestibular diagnoses [4].\n\nAt-home practice typically involves sessions of 10–20 minutes twice daily, and most improvement occurs within 6–8 weeks of consistent training. The key principle is graded exposure: repeatedly performing movements that provoke mild dizziness, which teaches the brain to recalibrate its vestibular processing.\n\nVitamin D: Protecting Against Recurrence\n\nOne of the most compelling and actionable findings in recent vertigo research is the role of vitamin D in preventing BPPV recurrence. Vitamin D is essential for calcium metabolism throughout the body, including in the ear. The otoconia — the calcium carbonate crystals whose displacement causes BPPV — appear to be more prone to fragmentation and dislodgement when systemic calcium and vitamin D signaling is impaired. Low serum vitamin D levels are significantly more common in BPPV patients than in age-matched controls, and patients with vitamin D deficiency have substantially higher recurrence rates.\n\nA large multicenter randomized trial across eight hospitals assigned BPPV patients with subnormal vitamin D (below 20 ng/mL) to either vitamin D supplementation (400 IU plus 500 mg calcium carbonate, twice daily) or observation for one year after successful repositioning treatment. The supplemented group's annual recurrence rate fell from 1.10 to 0.83 episodes per person-year — a statistically significant 24% reduction in absolute recurrence rate [2]. The effect was largest in patients with confirmed vitamin D deficiency.\n\nA subsequent meta-analysis including five trials confirmed the preventive effect (RR = 0.37; 95% CI 0.18–0.76), suggesting that bringing vitamin D levels to normal may reduce the risk of recurrence by more than half in deficient patients [3].\n\nGetting a 25-OH vitamin D blood test is a sensible step if BPPV keeps returning. Many practitioners target levels of 40–60 ng/mL for optimal vestibular and musculoskeletal health. See our vitamin D page for dosing and safety context.\n\nGinkgo Biloba for Vestibular Symptoms\n\nGinkgo biloba extract (particularly the standardized EGb 761 preparation) has been studied as an adjunct for vertigo and vestibular symptoms. Ginkgo's proposed mechanisms include improving cerebral and inner ear microcirculation, reducing platelet aggregation, and modulating neurotransmission in vestibular pathways — all of which may support vestibular compensation after an acute episode.\n\nA multicenter randomized double-blind trial compared EGb 761 at 240 mg/day with betahistine (a common pharmaceutical for vestibular vertigo) at 32 mg/day in 160 patients over 12 weeks. Both treatments produced similar rates of clinically meaningful improvement — 79% rated \"very much or much improved\" with EGb 761 versus 70% with betahistine — and Ginkgo was better tolerated, with fewer adverse events [5]. While this trial did not include a placebo arm (making it impossible to determine absolute effect size), the finding that Ginkgo matched an established pharmaceutical is notable.\n\nBetahistine is not widely approved in the US (though it is available in Canada and Europe), so for patients seeking non-pharmaceutical support for vestibular symptoms, Ginkgo at the EGb 761 standardized dose (240 mg/day) is a reasonable option with a plausible mechanism and good safety profile.\n\nReducing Recurrence: Lifestyle Factors\n\nFor people who experience repeated BPPV episodes:\n\n- Check vitamin D levels — as above, this is the most evidence-based prevention step\n- Avoid prolonged immobility — extended bed rest, particularly sleeping in one position, may increase crystal accumulation; sleeping with the head slightly elevated (at least 20 degrees) is a common clinical recommendation\n- Dietary calcium — since otoconia are calcium-based, ensuring adequate (but not excessive) dietary calcium through foods rather than high-dose supplements supports normal otoconia structure\n- Head injury avoidance — blunt trauma to the head is a significant BPPV trigger; protective equipment during sports is relevant for susceptible individuals\n- Treat underlying osteoporosis — low bone density is associated with higher BPPV risk; addressing calcium and vitamin D metabolism broadly reduces that risk. See our osteoporosis page","deepText":"Evidence Review\n\nThe Epley Maneuver: Cochrane Evidence\n\nHilton and Pinder 2014 (PMID 25485940) produced the most comprehensive synthesis of evidence for canalith repositioning maneuvers. This Cochrane review (updated in 2014) analyzed 11 randomized trials comprising 745 patients with BPPV confirmed by positive Dix-Hallpike test. Five trials compared Epley to sham maneuver, three compared it to other particle repositioning maneuvers (Semont, Brandt-Daroff, Gans), and three compared it to controls (no treatment, medication, postural restriction alone).\n\nThe Epley maneuver was significantly more effective than sham treatment in the short term (conversion to negative Dix-Hallpike in approximately 52–80% of patients vs. 10–25% for sham). The relative benefit was striking: odds ratio approximately 8:1 in favor of Epley over sham. The review concluded that the Epley maneuver is safe, effective, and the appropriate first-line treatment for posterior canal BPPV. No serious adverse effects were reported across any of the trials. Comparisons between Epley and the Semont maneuver showed similar effectiveness; the Epley maneuver is generally preferred because it is easier to administer in clinical settings.\n\nLimitations include heterogeneity in diagnostic criteria across trials, short follow-up periods in most studies, and limited data on recurrence prevention. The review found insufficient evidence to support routine use of post-maneuver activity restrictions.\n\nVitamin D Supplementation: Primary RCT\n\nJeong et al. 2020 (PMID 32759193) conducted the landmark randomized trial on vitamin D supplementation for BPPV recurrence prevention. This investigator-initiated, multicenter, blinded-outcome assessor, parallel-group RCT was conducted across eight hospitals in South Korea from December 2013 through May 2017. A total of 1,050 patients with confirmed BPPV were successfully treated with canalith repositioning maneuvers and then randomized: 518 to the intervention group and 532 to observation. Intervention patients with subnormal serum vitamin D (below 20 ng/mL) received vitamin D 400 IU plus calcium carbonate 500 mg twice daily for one year; patients with normal levels received no supplementation but were still included in the intervention arm.\n\nThe primary outcome was the annual BPPV recurrence rate during the 12-month follow-up. The intervention group had a recurrence rate of 0.83 episodes per person-year (95% CI 0.74–0.92) versus 1.10 (95% CI 1.00–1.19) in the observation group — an incidence rate ratio of 0.76 (95% CI 0.66–0.87, p < 0.001). Among participants who actually had subnormal vitamin D at baseline (about 38% of the cohort), the benefit was larger. The intervention was well-tolerated with no significant adverse events related to supplementation.\n\nKey limitation: the vitamin D group also received calcium supplementation, making it impossible to isolate vitamin D's contribution from calcium's. However, the mechanistic plausibility specifically implicates vitamin D in otoconia calcium metabolism.\n\nVitamin D Meta-Analysis\n\nJeong, Lee, and Kim 2022 (PMID 32767116) published a meta-analysis synthesizing five trials (four non-randomized and one RCT) involving 1,250 patients examining vitamin D supplementation for BPPV recurrence prevention. The pooled analysis found a significant preventive effect: RR = 0.37 (95% CI 0.18–0.76, p = 0.007) using random-effects modeling. This suggests vitamin D supplementation may cut recurrence risk by approximately 63% in patients with deficiency or insufficiency.\n\nThe meta-analysis is limited by heterogeneity among included studies (differing vitamin D doses, definitions of deficiency, and follow-up periods) and the predominance of non-randomized studies. The authors concluded that vitamin D supplementation should be considered in patients with frequent BPPV attacks, particularly when serum 25-OH vitamin D is subnormal — a conservative and well-supported recommendation given the favorable benefit-to-risk profile of correcting deficiency.\n\nVestibular Rehabilitation: Systematic Review\n\nKundakci et al. 2018 (PMID 29862019) systematically reviewed exercise-based vestibular rehabilitation in adults with chronic dizziness across five databases including Cochrane Central, MEDLINE, PubMed, PEDro, and Scopus. Four RCTs (687 total participants, predominantly female) met inclusion criteria. All four studies found significant between-group differences favoring vestibular rehabilitation over routine medical care for balance, fall risk, and vertigo symptom scores. Improvements in the Vertigo Symptom Scale, Berg Balance Scale, and Timed Up and Go test were consistently greater in the VR groups. Emotional wellbeing also improved significantly alongside physical outcomes.\n\nThe review included patients with various vestibular diagnoses (unilateral vestibular hypofunction, post-neuritis, general chronic dizziness) rather than isolated BPPV. The consistently positive findings across heterogeneous populations suggest vestibular rehabilitation has broad applicability beyond any single diagnosis. Limitations include the small number of included trials and variation in exercise protocols. The review did not perform formal meta-analysis due to heterogeneity.\n\nGinkgo biloba vs. Betahistine: RCT\n\nSokolova, Hoerr, and Mishchenko 2014 (PMID 25057270) conducted a multicenter, randomized, double-blind, parallel-group trial in patients with vertigo (mean age 58 years) comparing EGb 761 at 240 mg/day with betahistine at 32 mg/day for 12 weeks. 160 patients were enrolled across multiple sites. The primary outcome was improvement in the primary vertigo symptom and clinical global impression. …","deepTruncated":true,"references":[{"id":"1","title":"The Epley (canalith repositioning) manoeuvre for benign paroxysmal positional vertigo","authors":"Hilton MP, Pinder DK","year":2014,"journal":"Cochrane Database of Systematic Reviews","pmid":"25485940","url":"https://pubmed.ncbi.nlm.nih.gov/25485940/"},{"id":"2","title":"Prevention of benign paroxysmal positional vertigo with vitamin D supplementation: a randomized trial","authors":"Jeong SH, Kim JS, Kim HJ, Choi JY, Koo JW, Choi KD, Park JY, Lee SH, Choi SY, Oh SY, Yang TH, Park JH, Jung I, Ahn S, Kim S","year":2020,"journal":"Neurology","pmid":"32759193","url":"https://pubmed.ncbi.nlm.nih.gov/32759193/"},{"id":"3","title":"Prevention of recurrent benign paroxysmal positional vertigo with vitamin D supplementation: a meta-analysis","authors":"Jeong SH, Lee SU, Kim JS","year":2022,"journal":"Journal of Neurology","pmid":"32767116","url":"https://pubmed.ncbi.nlm.nih.gov/32767116/"},{"id":"4","title":"The effectiveness of exercise-based vestibular rehabilitation in adult patients with chronic dizziness: a systematic review","authors":"Kundakci B, Sultana A, Taylor AJ, Alshehri MA","year":2018,"journal":"F1000Research","pmid":"29862019","url":"https://pubmed.ncbi.nlm.nih.gov/29862019/"},{"id":"5","title":"Treatment of vertigo: a randomized, double-blind trial comparing efficacy and safety of Ginkgo biloba extract EGb 761 and betahistine","authors":"Sokolova L, Hoerr R, Mishchenko T","year":2014,"journal":"International Journal of Otolaryngology","pmid":"25057270","url":"https://pubmed.ncbi.nlm.nih.gov/25057270/"}],"wordCount":2552,"source":{"path":"src/content/topics/vertigo/natural-management.md"},"citeAs":"“Does the Epley maneuver cure vertigo, and can vitamin D stop it returning?.” What's Healthy and Why. https://whatshealthyandwhy.com/vertigo/natural-management","notice":"General information backed by peer-reviewed research, not medical advice."}